Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis.

disease-modifying treatments efficacy genomics metabolomics multiple sclerosis proteomics safety transcriptomics

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2023
Historique:
received: 21 10 2022
accepted: 09 01 2023
entrez: 16 2 2023
pubmed: 17 2 2023
medline: 17 2 2023
Statut: epublish

Résumé

From the perspective of precision medicine, the challenge for the future is to improve the accuracy of diagnosis, prognosis, and prediction of therapeutic responses through the identification of biomarkers. In this framework, the

Identifiants

pubmed: 36793897
doi: 10.3389/fgene.2023.1076421
pii: 1076421
pmc: PMC9922720
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1076421

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2023 Lorena, Maristella, Federica, Giuseppe, Luigi and Eleonora.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Neurol Neuroimmunol Neuroinflamm. 2018 Jun 12;5(4):e470
pubmed: 30283812
Nat Genet. 2015 Aug;47(8):856-60
pubmed: 26121088
Curr Med Chem. 2017;24(2):176-192
pubmed: 27881065
Int J Mol Sci. 2017 Feb 08;18(2):
pubmed: 28208701
PLoS One. 2015 Mar 03;10(3):e0117403
pubmed: 25734800
J Neuroimmunol. 2012 Jul 15;248(1-2):58-65
pubmed: 22281286
Sci Data. 2017 Sep 26;4:170138
pubmed: 29989594
Eur J Neurol. 2015 Mar;22(3):591-9
pubmed: 25104396
Medchemcomm. 2019 Aug 12;10(10):1803-1809
pubmed: 31803396
Brain. 2011 Jul;134(Pt 7):1914-24
pubmed: 21653539
CNS Drugs. 2022 Aug;36(8):803-817
pubmed: 35869335
Sci Rep. 2019 Aug 5;9(1):11313
pubmed: 31383928
J Proteomics. 2011 Nov 18;74(12):2826-36
pubmed: 21757039
Mult Scler Relat Disord. 2020 Sep;44:102189
pubmed: 32516740
Nat Rev Neurol. 2017 Jan;13(1):25-36
pubmed: 27934854
Brain Commun. 2020 Aug 14;2(2):fcaa119
pubmed: 33005893
JCI Insight. 2017 Oct 5;2(19):
pubmed: 28978801
Pharmacogenomics J. 2017 Jul;17(4):312-318
pubmed: 27001119
Sci Adv. 2016 Jun 17;2(6):e1501678
pubmed: 27386562
Metabolites. 2020 Sep 08;10(9):
pubmed: 32911763
BMC Med Genomics. 2014 May 17;7:26
pubmed: 24885345
Neurotherapeutics. 2019 Jul;16(3):797-807
pubmed: 30820880
Clin Immunol. 2016 Dec;173:133-146
pubmed: 27720845
Nat Commun. 2018 Jul 16;9(1):2755
pubmed: 30013029
Nat Genet. 2013 Nov;45(11):1353-60
pubmed: 24076602
J Neurol Sci. 1996 Dec;144(1-2):182-90
pubmed: 8994122
Sci Adv. 2020 Sep 10;6(37):
pubmed: 32917698
Sci Rep. 2018 Nov 27;8(1):17418
pubmed: 30479356
J Neuroimmune Pharmacol. 2007 Jun;2(2):184-93
pubmed: 18040843
J Mol Neurosci. 2007;32(3):169-78
pubmed: 17873362
Genomics. 2016 Jun;107(6):223-30
pubmed: 27141884
Mult Scler Relat Disord. 2022 Apr;60:103714
pubmed: 35245816
Brain. 2022 Sep 14;145(9):3147-3161
pubmed: 35104840
Neurol Neuroimmunol Neuroinflamm. 2015 Dec 24;3(1):e185
pubmed: 26740964
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Neurochem Int. 2018 Jan;112:1-4
pubmed: 29080803
Arch Biochem Biophys. 2021 Jan 15;697:108672
pubmed: 33189653
PLoS One. 2019 May 29;14(5):e0217208
pubmed: 31141529
Mult Scler. 2014 Sep;20(10):1396-400
pubmed: 24468817
Nat Rev Drug Discov. 2013 Aug;12(8):581-94
pubmed: 23868113
PLoS Genet. 2014 May 15;10(5):e1004383
pubmed: 24830394
Anal Chem. 2018 Jan 2;90(1):374-397
pubmed: 29166560
J Cell Biochem. 2011 Jul;112(7):1930-7
pubmed: 21445879
Autoimmunity. 2006 Dec;39(8):651-62
pubmed: 17178562
Front Neurol. 2015 Dec 10;6:257
pubmed: 26696956
Front Immunol. 2018 Jul 25;9:1693
pubmed: 30090102
Front Hum Neurosci. 2018 Jun 04;12:226
pubmed: 29915533
Biomark Insights. 2021 May 6;16:11772719211013352
pubmed: 34017167
Anal Bioanal Chem. 2020 Apr;412(10):2191-2209
pubmed: 31820027
Acta Neuropathol. 2012 Sep;124(3):397-410
pubmed: 22810490
Int J Mol Sci. 2022 May 05;23(9):
pubmed: 35563559
J Proteome Res. 2017 Jan 6;16(1):179-194
pubmed: 27728768
Mult Scler. 2014 Jul;20(8):1033-41
pubmed: 24336351
Continuum (Minneap Minn). 2022 Aug 1;28(4):988-1005
pubmed: 35938654
Nat Commun. 2019 May 7;10(1):2094
pubmed: 31064978
Nature. 2011 Aug 10;476(7359):214-9
pubmed: 21833088
J Neuroimmunol. 2010 Jan 25;218(1-2):112-5
pubmed: 19923011
Cell Rep Med. 2021 Apr 20;2(4):100246
pubmed: 33948576
Continuum (Minneap Minn). 2022 Aug 1;28(4):1083-1103
pubmed: 35938658
BMC Neurol. 2013 May 21;13:45
pubmed: 23692923
Nat Genet. 2020 Oct;52(10):1036-1045
pubmed: 32929287
Hum Mol Genet. 2010 Sep 15;19(18):3679-89
pubmed: 20634196
Cell Rep Med. 2021 Oct 19;2(10):100424
pubmed: 34755135
Nat Commun. 2016 Apr 19;7:11263
pubmed: 27090007
Clin Epigenetics. 2015 Nov 05;7:118
pubmed: 26550040
Nat Genet. 2010 Jun;42(6):495-7
pubmed: 20453840
Pharmacogenomics J. 2022 Feb;22(1):75-81
pubmed: 34741133
Lancet Neurol. 2009 Dec;8(12):1111-9
pubmed: 19879194
PLoS One. 2007 Jul 04;2(7):e595
pubmed: 17611627
J Clin Med. 2020 Mar 21;9(3):
pubmed: 32245176
Front Immunol. 2020 Jul 17;11:1527
pubmed: 32765529
J Proteomics. 2018 Sep 15;187:212-222
pubmed: 30086402
Front Neurol. 2020 Dec 03;11:579683
pubmed: 33343487
Expert Rev Neurother. 2022 May;22(5):393-403
pubmed: 35400266
Sci Rep. 2017 Feb 03;7:41473
pubmed: 28155867
N Engl J Med. 1986 Dec 25;315(26):1638-42
pubmed: 3785335
Nat Rev Genet. 2015 Jun;16(6):321-32
pubmed: 25948244
Ann Neurol. 2020 Sep;88(3):438-452
pubmed: 32506714
Clin Sci (Lond). 2018 Aug 17;132(17):1963-1976
pubmed: 30219773
J Proteomics. 2015 Apr 06;118:2-11
pubmed: 25753122
Cells. 2019 Jan 24;8(2):
pubmed: 30678351
Mult Scler. 2015 Apr;21(4):433-41
pubmed: 25257611
Nature. 2013 Sep 26;501(7468):506-11
pubmed: 24037378
Breast Care (Basel). 2020 Aug;15(4):355-365
pubmed: 32982645
Nat Biotechnol. 2012 Jan 09;30(1):69-77
pubmed: 22231104
Mol Neurobiol. 2017 Nov;54(9):7520-7533
pubmed: 27826747
Mult Scler. 2019 Jan;25(1):23-30
pubmed: 29111883
N Engl J Med. 2017 Apr 27;376(17):1615-1626
pubmed: 28445677
Brain. 2023 Feb 13;146(2):645-656
pubmed: 35253861
Nat Commun. 2019 Apr 23;10(1):1891
pubmed: 31015401
Neurology. 2009 Nov 3;73(18):1485-92
pubmed: 19884576
Front Neurol. 2022 May 26;13:874121
pubmed: 35693010
Sci Rep. 2018 Feb 15;8(1):3071
pubmed: 29449691
Hum Mol Genet. 2019 Nov 21;28(R2):R133-R142
pubmed: 31363735
Neurotherapeutics. 2020 Oct;17(4):1768-1784
pubmed: 33058021
Nat Commun. 2019 Jul 1;10(1):2956
pubmed: 31263110
Mult Scler. 2009 Dec;15(12):1525-7
pubmed: 19965514
Mol Cell Proteomics. 2017 Jan;16(1):86-99
pubmed: 27879288
Sci Rep. 2017 Aug 18;7(1):8727
pubmed: 28821874
Ann Clin Transl Neurol. 2018 Oct 30;6(1):33-45
pubmed: 30656182
J Proteome Res. 2016 Feb 5;15(2):659-66
pubmed: 26759122
Nat Rev Drug Discov. 2014 Jun;13(6):419-31
pubmed: 24833294
Mult Scler. 2014 May;20(6):675-85
pubmed: 24126065
Trends Genet. 2018 Jul;34(7):558-570
pubmed: 29803319
Science. 2019 Sep 27;365(6460):
pubmed: 31604244
Int J Mol Sci. 2013 Aug 05;14(8):16087-110
pubmed: 23921681
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
N Engl J Med. 2007 Aug 30;357(9):851-62
pubmed: 17660530
Pharmacogenet Genomics. 2016 Mar;26(3):103-15
pubmed: 26678572
Ann Neurol. 2011 Dec;70(6):897-912
pubmed: 22190364
J Neuroimmunol. 2020 Nov 15;348:577385
pubmed: 32927398
Nat Commun. 2018 Jun 19;9(1):2397
pubmed: 29921915
Nat Commun. 2021 Dec 6;12(1):7078
pubmed: 34873174
PLoS One. 2017 Jul 26;12(7):e0181758
pubmed: 28746356
BMC Med. 2020 Nov 4;18(1):298
pubmed: 33143745
Cell Physiol Biochem. 2014;34(1):111-8
pubmed: 24977485
Magn Reson Chem. 2013 Feb;51(2):102-9
pubmed: 23255426
Brief Bioinform. 2018 Mar 1;19(2):325-340
pubmed: 28011753
Drugs. 2010 Aug 20;70(12):1545-77
pubmed: 20687620
Mult Scler Relat Disord. 2021 May;50:102816
pubmed: 33571792
Acta Naturae. 2016 Jul-Sep;8(3):103-110
pubmed: 27795849
Clin Epigenetics. 2017 Jul 18;9:71
pubmed: 28729889
Biomark Med. 2016 Aug;10(8):889-902
pubmed: 27416337
Neurol Neuroimmunol Neuroinflamm. 2017 Jan 27;4(2):e321
pubmed: 28180139
Handb Clin Neurol. 2016;135:399-423
pubmed: 27432676
Brain. 2014 Aug;137(Pt 8):2271-86
pubmed: 24893707
Clin Epigenetics. 2016 Aug 27;8(1):87
pubmed: 27570566
Mass Spectrom Rev. 2007 May-Jun;26(3):432-50
pubmed: 17405153
Neuromolecular Med. 2010 Dec;12(4):351-61
pubmed: 20607622
J Mol Endocrinol. 2018 Jul 13;:
pubmed: 30006342
Ann Clin Transl Neurol. 2018 Sep 27;5(10):1211-1221
pubmed: 30349856
Hum Mol Genet. 2018 Jan 1;27(1):66-79
pubmed: 29087462
Genome Med. 2017 May 31;9(1):50
pubmed: 28569182

Auteurs

Lorena Lorefice (L)

Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Maristella Pitzalis (M)

Institute for Genetic and Biomedical Research, National Research Council, Cagliari, Italy.

Federica Murgia (F)

Dpt of Biomedical Sciences, University of Cagliari, Cagliari, Italy.

Giuseppe Fenu (G)

Department of Neurosciences, ARNAS Brotzu, Cagliari, Italy.

Luigi Atzori (L)

Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Eleonora Cocco (E)

Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Classifications MeSH